Abstract
Treatment options for hair loss have traditionally been limited to topical and systemic therapies. Systemic therapies for inflammatory hair disorders are often immunosuppressive, and systemic treatment of androgenetic hair loss can cause undesired effects on sexual and reproductive health. Topical agents have a favorable side effect profile compared with systemic therapies, but many topicals have poor transcutaneous absorption, limiting their concentration and action at follicular targets in the dermis.
Original language | English (US) |
---|---|
Pages (from-to) | 447-461 |
Number of pages | 15 |
Journal | Dermatologic Clinics |
Volume | 39 |
Issue number | 3 |
DOIs | |
State | Published - Jul 2021 |
Bibliographical note
Funding Information:The authors have nothing to disclose.
Keywords
- Alopecia
- Devices
- Fractionated Lasers
- Laser-Assisted Drug Deliver
- Low-Level Laser Light
- Microneedling
- Photobiomodulation